Long answer question (15marks) 1. Write a detail note on urea cycle with reaction? Mention its major metablic disorders . 2. Explain the transamination reaction ? Involved in the catabolism of amino acids. 3. What are the bile pigments. Name the diseases aassociated with their metablism. 4. What are transaminase. Write the fiagnostic importance of transaminases. 5. What are porphyrin. Explain the type and clinical importance of porphyria. Short answer question ( 5 marks) 1. Explain the transamination reaction involved in thr catabolism of amino avids. 2. Explain phenoketoneumia and alkaptoneumia 3. What is porphyria? 4. What is jaundice? Explain the different types of jaundice? 5. What is normal blood urea level? Name two condition in which blood urea level is elevated . Answer these as per exam answer which includes flowcharts, pictures, tables as per long question with 15 marks answer and short question for 5 marks answer for pharm d student in understandable language

Reading File

Finding Sources

Reading File

Finding Sources

Reading File

I now have sufficient textbook content to write comprehensive exam answers. Let me compile everything.

📚 BIOCHEMISTRY EXAM ANSWERS — Pharm.D.

🔵 LONG ANSWER QUESTIONS (15 Marks Each)

Q1. Urea Cycle — Detailed Note with Reactions & Metabolic Disorders

Introduction

The urea cycle (Krebs-Henseleit cycle, discovered 1932) is the principal pathway by which the liver converts toxic ammonia (NH₃) into the non-toxic, water-soluble compound urea (H₂N-CO-NH₂), which is then excreted in the urine by the kidneys.

Urea accounts for ~90% of nitrogen-containing urinary components
Normal blood urea nitrogen (BUN): 8–20 mg/dL (serum urea ~20–40 mg/dL)
One nitrogen of urea comes from free NH₃ (via GDH); the other from aspartate
Carbon and oxygen come from CO₂ (HCO₃⁻)

Overall Equation

NH₃ + CO₂ + Aspartate + 3ATP + H₂O → Urea + Fumarate + 2ADP + AMP + 4Pi

Location

Steps	Location
Steps 1–2 (Carbamoyl phosphate & Citrulline formation)	Mitochondrial matrix
Steps 3–5 (Argininosuccinate synthesis, cleavage, Arginase)	Cytosol

Steps of the Urea Cycle — Flowchart

MITOCHONDRIA
══════════════════════════════════════════════════════════════
NH₃ + CO₂ + 2ATP + H₂O
        ↓  [Carbamoyl Phosphate Synthetase I (CPS-I)]
        ↓  (requires N-Acetylglutamate as allosteric activator)
   CARBAMOYL PHOSPHATE
        ↓  [Ornithine Transcarbamylase (OTC)]
   Ornithine + Carbamoyl Phosphate → CITRULLINE + Pi
        ↓
   Citrulline exits to CYTOSOL (via antiporter)
══════════════════════════════════════════════════════════════
CYTOSOL
═══════════════════════════════════════════════════════════════
   Citrulline + Aspartate + ATP
        ↓  [Argininosuccinate Synthetase]
   ARGININOSUCCINATE (+ AMP + PPi)
        ↓  [Argininosuccinate Lyase]
   ARGININE + FUMARATE
        ↓  [Arginase-I (liver only)]
   ORNITHINE + UREA ←── excreted in urine
        ↓
   Ornithine re-enters mitochondria → cycle repeats
═══════════════════════════════════════════════════════════════

Detailed Reaction Steps

Step	Reaction	Enzyme	Location	Energy
1	NH₃ + CO₂ → Carbamoyl Phosphate	CPS-I	Mitochondria	2 ATP consumed
2	Carbamoyl-P + Ornithine → Citrulline	OTC	Mitochondria	—
3	Citrulline + Aspartate → Argininosuccinate	Argininosuccinate synthetase	Cytosol	1 ATP (→AMP+PPi)
4	Argininosuccinate → Arginine + Fumarate	Argininosuccinate lyase	Cytosol	—
5	Arginine → Ornithine + Urea	Arginase-I	Cytosol	—

Total energy cost: 3 ATP equivalents per urea molecule (2 ATP + 1 ATP as AMP)

Regulation of the Urea Cycle

N-Acetylglutamate (NAG) is the essential allosteric activator of CPS-I
NAG is synthesized from acetyl-CoA + glutamate by NAG synthase (NAGS)
Arginine stimulates NAGS → more NAG → more urea synthesis (feed-forward)
High protein diet increases urea cycle enzyme expression

Link with TCA Cycle (Krebs Bicycle)

Fumarate (urea cycle product)
    ↓ Fumarase
   Malate
    ↓ Malate Dehydrogenase
   Oxaloacetate
    ↓ Transamination (AST)
   Aspartate → re-enters urea cycle at Step 3

Major Metabolic Disorders of the Urea Cycle

All urea cycle disorders (UCDs) cause hyperammonemia, which is toxic to the brain.

Disorder	Deficient Enzyme	Accumulated Metabolite	Key Features
OTC Deficiency (most common)	Ornithine Transcarbamylase	Carbamoyl phosphate → ↑orotic acid in urine	X-linked; males affected; hyperammonemia, encephalopathy
Citrullinemia Type I	Argininosuccinate Synthetase	↑Citrulline in blood & urine	Neonatal acute form; neurological damage
Argininosuccinic Aciduria	Argininosuccinate Lyase	↑Argininosuccinic acid in urine	Hair abnormality (trichorrhexis nodosa)
Arginase Deficiency	Arginase-I	↑Arginine; mild hyperammonemia	Progressive spastic diplegia, intellectual disability
CPS-I Deficiency	Carbamoyl Phosphate Synthetase I	↑NH₃; ↓citrulline, orotic acid normal	Rare; severe neonatal hyperammonemia
NAGS Deficiency	N-Acetylglutamate Synthase	Same as CPS-I deficiency	Rarest; responds to N-carbamylglutamate treatment

Common symptoms of all UCDs:

Hyperammonemia → nausea, vomiting, lethargy, tremors, seizures, cerebral edema, coma, death

Treatment:

Low-protein diet
Ammonia scavengers (sodium benzoate, sodium phenylbutyrate)
Arginine/citrulline supplementation
Liver transplant in severe cases

Source: Lippincott's Illustrated Reviews Biochemistry, 8th ed.; Basic Medical Biochemistry, 6th ed.

Q2. Transamination Reaction in Catabolism of Amino Acids

Definition

Transamination is the transfer of an α-amino group from an amino acid to an α-keto acid, resulting in the formation of a new amino acid and a new keto acid. It is the primary route for removal of nitrogen from amino acids.

General Reaction

Amino Acid₁  +  α-Keto Acid₂  ⇌  α-Keto Acid₁  +  Amino Acid₂
     ↕                                     ↕
  (donates NH₂)                      (accepts NH₂)

Most important pair involved:

Any Amino Acid  +  α-Ketoglutarate  ⇌  Corresponding α-Keto Acid  +  Glutamate

Glutamate acts as the central collector of amino groups.

Key Example Reactions

1. Alanine Aminotransferase (ALT / SGPT)

Alanine  +  α-Ketoglutarate  ⇌  Pyruvate  +  Glutamate

2. Aspartate Aminotransferase (AST / SGOT)

Aspartate  +  α-Ketoglutarate  ⇌  Oxaloacetate  +  Glutamate

Mechanism — "Ping-Pong" Mechanism

Step 1: Amino acid reacts with PLP (Pyridoxal Phosphate) bound to enzyme
           → Schiff base formed → rearranges
           → α-Keto acid released + Enzyme-PMP (Pyridoxamine Phosphate) formed

Step 2: PMP reacts with incoming α-keto acid (α-ketoglutarate)
           → New amino acid (Glutamate) released
           → PLP regenerated on enzyme

Enzyme-PLP  +  Amino Acid  →  Enzyme-PMP  +  α-Keto Acid
                                     ↓
Enzyme-PMP  +  α-Ketoglutarate  →  Enzyme-PLP  +  Glutamate

Cofactor

Cofactor	Vitamin Precursor	Role
Pyridoxal Phosphate (PLP)	Vitamin B₆ (Pyridoxine)	Carries amino group; forms Schiff base with α-amino group of substrate

Role in Amino Acid Catabolism

DIETARY PROTEIN
     ↓ (digestion)
AMINO ACIDS
     ↓ (Transamination)
α-Keto Acids → TCA cycle → Energy (CO₂ + H₂O) or Gluconeogenesis
     ↓
Glutamate
     ↓ (Oxidative Deamination by GDH)
α-Ketoglutarate + NH₃
     ↓
UREA CYCLE → UREA (excreted)

Significance

Role	Detail
Nitrogen removal	Channels amino groups from all amino acids into glutamate
Reversible	Also functions in amino acid biosynthesis
Links metabolism	Connects amino acid metabolism to TCA cycle
All except two	Lysine and Threonine do NOT undergo transamination

Source: Harper's Illustrated Biochemistry, 32nd ed.; Basic Medical Biochemistry, 6th ed.

Q3. Bile Pigments — Definition, Metabolism & Associated Diseases

What are Bile Pigments?

Bile pigments are colored breakdown products of heme. The principal bile pigment is bilirubin, which gives bile its yellow color and is responsible for jaundice when accumulated.

Source of Bile Pigments

Aged/Damaged RBCs (80–85%)  +  Other heme proteins (myoglobin, cytochromes) (15–20%)
                              ↓
                         HEME
                              ↓  [Heme oxygenase] (reticuloendothelial system)
                         BILIVERDIN (green) + CO + Fe²⁺
                              ↓  [Biliverdin reductase]
                         BILIRUBIN (yellow-orange) — Unconjugated / Indirect bilirubin

Types of Bilirubin

Feature	Unconjugated (Indirect) Bilirubin	Conjugated (Direct) Bilirubin
Solubility	Water-insoluble (lipid-soluble)	Water-soluble
Transport in blood	Bound to albumin	Free in plasma
Van den Bergh reaction	Indirect (needs alcohol)	Direct (reacts directly)
Renal excretion	NOT excreted in urine	Excreted in urine (bilirubinuria)
Normal plasma level	0.1–0.8 mg/dL	0.0–0.3 mg/dL
Total normal bilirubin	0.3–1.0 mg/dL

Metabolism of Bile Pigments — Flowchart

SPLEEN / RES
Heme → Biliverdin → UNCONJUGATED BILIRUBIN
                          ↓ (bound to albumin)
                     LIVER
                          ↓ [UDP-Glucuronyltransferase (UGT1A1)]
                     CONJUGATED BILIRUBIN (bilirubin diglucuronide)
                          ↓ (secreted into bile)
                     INTESTINE
                          ↓ [Gut bacteria — β-glucuronidase]
                     UROBILINOGEN
                        /              \
                (10–20%)              (80–90%)
                BLOOD                INTESTINE
                  ↓                     ↓
              KIDNEY              STERCOBILINOGEN → STERCOBILIN
                ↓                  (brown color of feces)
            UROBILIN
         (yellow color of urine)

Diseases Associated with Bile Pigment Metabolism

Disease	Type	Bilirubin Affected	Mechanism
Hemolytic Jaundice	Pre-hepatic	↑ Unconjugated	Excess RBC destruction overwhelms liver conjugation
Gilbert's Syndrome	Intrahepatic	↑ Unconjugated	↓ UGT1A1 activity (~30%); benign; triggered by fasting/stress
Crigler-Najjar Syndrome Type I	Intrahepatic	↑↑ Unconjugated	Complete absence of UGT1A1; lethal without treatment (phototherapy/transplant)
Crigler-Najjar Syndrome Type II	Intrahepatic	↑ Unconjugated	Partial UGT1A1 deficiency; less severe
Dubin-Johnson Syndrome	Intrahepatic	↑ Conjugated	Defect in MRP2 transporter (canalicular excretion defect); benign
Rotor Syndrome	Intrahepatic	↑ Conjugated	Impaired hepatic uptake and storage; benign
Obstructive Jaundice	Post-hepatic	↑ Conjugated	Bile duct obstruction (gallstones, carcinoma, cholangitis)
Neonatal Jaundice	Physiological	↑ Unconjugated	Immature UGT1A1; self-limiting
Kernicterus	—	↑↑ Unconjugated	Bilirubin deposits in basal ganglia → brain damage

Q4. Transaminases — Definition & Diagnostic Importance

Definition

Transaminases (aminotransferases) are enzymes that catalyze transamination reactions — the transfer of an amino group from an amino acid to an α-keto acid. They require Pyridoxal Phosphate (PLP, Vitamin B₆) as a cofactor.

Important Transaminases

Enzyme	Full Name	Reaction Catalyzed	Location
ALT (SGPT)	Alanine Aminotransferase	Alanine + α-KG ⇌ Pyruvate + Glutamate	Predominantly liver (cytosol)
AST (SGOT)	Aspartate Aminotransferase	Aspartate + α-KG ⇌ OAA + Glutamate	Heart, liver, muscle, RBCs (mitochondria & cytosol)

α-KG = α-Ketoglutarate; OAA = Oxaloacetate

Normal Values

Enzyme	Normal Serum Level
ALT (SGPT)	7–56 U/L (men), 7–45 U/L (women)
AST (SGOT)	10–40 U/L
AST/ALT Ratio	~1:1 in normal

Diagnostic Importance of Transaminases

TISSUE DAMAGE
      ↓
Cell membrane disruption
      ↓
Intracellular transaminases leak into bloodstream
      ↓
↑ Serum AST and/or ALT
      ↓
Indicates organ damage (type depends on ratio and magnitude)

1. Liver Diseases

Condition	ALT	AST	AST/ALT Ratio	Notes
Viral Hepatitis	↑↑↑ (>1000 U/L)	↑↑	<1 (ALT>AST)	ALT most sensitive liver marker
Alcoholic Hepatitis	↑	↑↑	>2:1	De Ritis ratio; AST rises more due to mitochondrial damage
Cirrhosis	↑ or normal	↑	>2:1	Moderate elevation
Obstructive Jaundice	↑	↑	Variable	ALP rises more than transaminases
Non-alcoholic fatty liver (NAFLD)	↑	↑	<1	ALT typically higher

2. Cardiac Diseases

Condition	AST	ALT	Notes
Acute MI	↑↑ (peaks 24–48 h)	Normal	Now replaced by Troponin; historically important
Cardiac surgery	↑	↑	Non-specific

3. Other Conditions

Condition	Transaminase Change
Skeletal muscle injury / Rhabdomyolysis	↑ AST
Hemolytic anemia	↑ AST
Pancreatitis	Mild ↑ ALT
Drug-induced hepatotoxicity (e.g., paracetamol overdose)	↑↑↑ ALT, AST
Hypothyroidism	Mild ↑ AST

De Ritis Ratio (AST/ALT)

Ratio	Interpretation
<1.0	Viral hepatitis, NAFLD
>2.0	Alcoholic liver disease
>3.0	Strongly suggestive of alcoholic hepatitis

Q5. Porphyrins — Types and Clinical Importance of Porphyria

What are Porphyrins?

Porphyrins are cyclic organic compounds made of four pyrrole rings linked by methine bridges (=CH−). They have a strong ability to chelate metal ions — the most important being iron (Fe²⁺) to form heme.

Heme = Porphyrin (protoporphyrin IX) + Fe²⁺

Heme Biosynthesis — Summary Flowchart

MITOCHONDRIA
Succinyl-CoA + Glycine
        ↓  [ALA Synthase — rate-limiting enzyme; requires PLP]
        ↓  (inhibited by heme — feedback inhibition)
   δ-Aminolevulinic Acid (ALA)
        ↓ exits to CYTOSOL

CYTOSOL
   2 ALA → Porphobilinogen (PBG)  [ALA Dehydratase]
        ↓
   4 PBG → Hydroxymethylbilane  [PBG Deaminase/HMB Synthase]
        ↓
   Uroporphyrinogen I / III  [Uroporphyrinogen Cosynthase]
        ↓
   Coproporphyrinogen III  [Uroporphyrinogen Decarboxylase]
        ↓ enters MITOCHONDRIA

MITOCHONDRIA
   Coproporphyrinogen III → Protoporphyrinogen IX  [Coproporphyrinogen Oxidase]
        ↓
   Protoporphyrinogen IX → Protoporphyrin IX  [Protoporphyrinogen Oxidase]
        ↓
   Protoporphyrin IX + Fe²⁺ → HEME  [Ferrochelatase]

What is Porphyria?

Porphyrias are a group of inherited (mostly autosomal dominant) metabolic disorders caused by deficiency of specific enzymes in the heme biosynthesis pathway. The deficiency leads to accumulation of porphyrin precursors (ALA, PBG, porphyrins), which are toxic.

Classification of Porphyrias

By Site of Overproduction

Type	Site	Examples
Hepatic Porphyrias	Liver	AIP, VP, HCP, PCT
Erythropoietic Porphyrias	Bone marrow	CEP (Günther disease), EPP

By Clinical Presentation

Type	Manifestation	Examples
Acute (Neurological)	Abdominal pain, neuropathy, psychiatric symptoms	AIP, HCP, VP
Cutaneous (Photosensitivity)	Skin blistering, scarring on sun exposure	PCT, CEP, EPP
Mixed (Acute + Cutaneous)	Both features	HCP, VP

Major Types of Porphyria — Table

Porphyria	Deficient Enzyme	Accumulates	Type	Key Features
AIP (Acute Intermittent Porphyria)	PBG Deaminase	ALA, PBG	Hepatic/Acute	No skin features; abdominal pain, neuropathy, psychiatric changes
PCT (Porphyria Cutanea Tarda) — most common	Uroporphyrinogen Decarboxylase	Uroporphyrins	Hepatic/Cutaneous	Blistering skin on sun exposure; associated with alcohol, iron overload, hepatitis C
CEP (Congenital Erythropoietic Porphyria / Günther disease)	Uroporphyrinogen Cosynthase	Uroporphyrin I	Erythropoietic/Cutaneous	Severe photosensitivity; pink/red urine; mutilating lesions; "werewolf legend"
EPP (Erythropoietic Protoporphyria)	Ferrochelatase	Protoporphyrin IX	Erythropoietic/Cutaneous	Painful photosensitivity WITHOUT blisters; hepatic complications
VP (Variegate Porphyria)	Protoporphyrinogen Oxidase	Protoporphyrin + ALA, PBG	Hepatic/Mixed	Acute + skin features; common in South Africans
HCP (Hereditary Coproporphyria)	Coproporphyrinogen Oxidase	Coproporphyrin III	Hepatic/Mixed	Acute + photosensitivity

Clinical Features of Acute Porphyria (The "5 Ps")

1. Pain — Severe abdominal pain (most common presentation)
2. Polyneuropathy — Peripheral and autonomic neuropathy
3. Psychiatric — Anxiety, hallucinations, seizures, confusion
4. Pink/Port-wine urine — Porphyrinogen oxidized on standing
5. Precipitants — Drugs (barbiturates, sulfonamides, OCP), fasting, alcohol, hormones

Diagnosis

Test	Finding in Acute Porphyria
Urine ALA, PBG	Markedly elevated
Urine color	Turns dark/reddish-brown on standing
Specific enzyme assay (RBCs/leukocytes)	Reduced activity
Genetic testing	Confirmatory

Treatment

Condition	Treatment
Acute attack	IV glucose (10–20 g/h) + IV hematin (2–5 mg/kg/day for 3–14 days)
Recurrent AIP	Givosiran (siRNA — inhibits ALA synthase mRNA in hepatocytes, 2.5 mg/kg SC/month)
PCT	Phlebotomy, low-dose chloroquine
EPP	Sun protection, beta-carotene

Source: Harrison's Principles of Internal Medicine, 22nd ed.; Lippincott's Illustrated Reviews Biochemistry, 8th ed.

🟢 SHORT ANSWER QUESTIONS (5 Marks Each)

SAQ 1. Transamination Reaction in Catabolism of Amino Acids

Definition

Transamination = reversible transfer of α-amino group from amino acid to α-keto acid, catalyzed by aminotransferases (transaminases), requiring PLP (Vitamin B₆) as cofactor.

General Reaction

Amino Acid + α-Ketoglutarate  ⇌  α-Keto Acid + Glutamate
            (Transaminase + PLP)

Examples

ALT:  Alanine + α-KG  ⇌  Pyruvate + Glutamate
AST:  Aspartate + α-KG  ⇌  OAA + Glutamate

Mechanism (Ping-Pong)

Enzyme-PLP + Amino Acid → Enzyme-PMP + α-Keto Acid
Enzyme-PMP + α-KG       → Enzyme-PLP + Glutamate

Significance in Catabolism

Removes nitrogen from amino acids without releasing free NH₃ directly
Channels all amino group nitrogen into glutamate
Glutamate undergoes oxidative deamination (GDH) → NH₃ → urea cycle
All amino acids except Lysine and Threonine undergo transamination
Links amino acid catabolism to TCA cycle via keto acids

SAQ 2. Phenylketonuria (PKU) and Alkaptonuria

A. Phenylketonuria (PKU)

Definition: Autosomal recessive disorder of phenylalanine metabolism due to deficiency of phenylalanine hydroxylase (PAH).

Biochemical Defect:

Phenylalanine  →  Tyrosine
                  (PAH blocked — requires BH4 as cofactor)
           ↓
Phenylalanine accumulates
           ↓ (alternative pathways activated)
Phenylpyruvate + Phenylacetate + Phenyllactate (phenyl ketones)
           ↓ excreted in urine → "phenylketonuria"

Feature	Detail
Inheritance	Autosomal recessive
Enzyme Deficient	Phenylalanine hydroxylase (PAH)
Cofactor	Tetrahydrobiopterin (BH₄)
Blood Phe level	>20 mg/dL (normal <2 mg/dL)
Urine	Musty/mousy odor (phenylacetate)
Clinical Features	Intellectual disability, seizures, eczema, fair skin/hair/eyes (↓ melanin), microcephaly
Screening	Guthrie test (newborn heel prick) — mandatory in most countries
Treatment	Phenylalanine-restricted diet (avoid aspartame); BH₄ supplementation (sapropterin) in some

B. Alkaptonuria

Definition: Autosomal recessive disorder due to deficiency of homogentisate oxidase (homogentisic acid oxidase).

Biochemical Defect:

Phenylalanine → Tyrosine
                    ↓
           Homogentisic acid (HGA)
                    ↓ [Homogentisate oxidase — BLOCKED]
           HGA accumulates → excreted in urine
                    ↓ (polymerizes)
           Ochronotic pigment (dark polymer) deposits in tissues

Feature	Detail
Enzyme Deficient	Homogentisate oxidase (homogentisic acid dioxygenase)
Gene	HGD gene
Urine finding	Darkens on standing/alkaline pH (dark brown-black)
Ochronosis	Blue-black pigment deposits in cartilage, tendons, sclera
Arthritis	Ochronotic arthropathy (large joint degeneration)
Cardiac	Valvular disease (deposits in heart valves)
Diagnosis	Urine HGA levels; dark urine on standing; genetic testing
Treatment	Nitisinone (NTBC) — reduces HGA; high-dose Vitamin C; low protein diet

Comparison Table: PKU vs. Alkaptonuria

Feature	PKU	Alkaptonuria
Deficient Enzyme	Phenylalanine hydroxylase	Homogentisate oxidase
Metabolite accumulated	Phenylalanine, phenylketones	Homogentisic acid
Urine	Musty odor, FeCl₃ → green	Darkens on standing
CNS involvement	Severe (intellectual disability)	None
Joint involvement	None	Yes (ochronotic arthropathy)
Onset symptoms	Early infancy	Middle age

SAQ 3. Porphyria

Definition

Porphyrias are a group of mostly inherited metabolic disorders caused by enzyme deficiencies in the heme biosynthesis pathway, leading to accumulation of toxic porphyrin precursors (ALA, PBG, uroporphyrins, coproporphyrins).

Classification

         PORPHYRIAS
         /         \
  HEPATIC          ERYTHROPOIETIC
  (liver)          (bone marrow)
     |                   |
  ┌──────────┐       ┌──────────┐
  │ Acute:   │       │ CEP      │
  │ AIP, VP, │       │ EPP      │
  │ HCP      │       └──────────┘
  │ Cutaneous│
  │ PCT      │
  └──────────┘

Key Features

Type	Main Symptom
AIP (most important acute type)	Abdominal pain + neuropsychiatric features; NO skin
PCT (most common overall)	Skin blistering on sun-exposed areas
CEP	Severe photosensitivity, mutilation, pink urine

Triggers of Acute Attacks

Drugs: barbiturates, sulfonamides, rifampicin, OCP, anticonvulsants
Fasting / low carbohydrate diet
Alcohol
Infection, stress, hormonal changes (menstruation)

Diagnosis: ↑ urinary ALA and PBG; red/pink urine darkening on standing

Treatment of Acute Attack:

IV Glucose (stops ALA synthase induction)
IV Hematin (heme arginate — provides feedback inhibition of ALA synthase)
Givosiran (for recurrent AIP — siRNA reducing ALA synthase mRNA)

SAQ 4. Jaundice — Definition, Types

Definition

Jaundice (icterus) is yellowish discoloration of skin, sclera, and mucous membranes due to elevated serum bilirubin (hyperbilirubinemia). Clinically detectable when bilirubin > 2.5–3 mg/dL.

Normal total bilirubin: 0.3–1.0 mg/dL

Bilirubin Metabolism (Brief)

RBC destruction → Heme → Biliverdin → Unconjugated Bilirubin (UCB)
UCB + Albumin → Liver → Conjugated Bilirubin (CB) [by UGT1A1]
CB → Bile → Intestine → Urobilinogen → Stercobilin (feces) / Urobilin (urine)

Types of Jaundice

         JAUNDICE
        /    |    \
PRE-HEPATIC  HEPATIC  POST-HEPATIC
(Hemolytic)  (Hepato-  (Obstructive)
             cellular)

Feature	Pre-hepatic (Hemolytic)	Hepatic (Hepatocellular)	Post-hepatic (Obstructive)
Cause	Excess RBC destruction	Liver cell damage	Bile duct obstruction
Examples	Hemolytic anemia, malaria, sickle cell, G6PD deficiency	Viral hepatitis, cirrhosis, drugs	Gallstones, carcinoma pancreas, cholangiocarcinoma
Bilirubin	↑ Unconjugated (indirect)	↑ Both (mixed)	↑ Conjugated (direct)
Urine bilirubin	Absent (no bilirubinuria)	Present	Present (dark urine)
Urine urobilinogen	↑↑ Increased	Variable	Absent/decreased
Stool color	Dark (normal/increased)	Pale	Clay/pale (acholic)
ALT/AST	Normal	↑↑↑	Mildly ↑
ALP	Normal	Mildly ↑	↑↑↑ (hallmark)
Prothrombin time	Normal	Prolonged (liver failure)	Prolonged (corrects with Vit K)

Specific Inherited Causes

Type	Syndrome	Bilirubin
Hepatic/Unconjugated	Gilbert's, Crigler-Najjar I & II	Unconjugated
Hepatic/Conjugated	Dubin-Johnson, Rotor	Conjugated

SAQ 5. Normal Blood Urea Level & Conditions with Elevated Blood Urea

Normal Blood Urea Levels

Measurement	Normal Range
Blood Urea Nitrogen (BUN)	8–20 mg/dL (2.9–7.1 mmol/L)
Serum Urea	20–40 mg/dL (3.3–6.7 mmol/L)
Normal NH₃ (plasma)	30–60 μmol/L

Urea is formed in the liver and excreted by kidneys. BUN reflects glomerular filtration rate (GFR) and protein catabolism.

Conditions with Elevated Blood Urea (Azotemia)

Elevated BUN is called azotemia; when symptomatic, it is called uremia.

Two Major Conditions:

1. Chronic Kidney Disease (CKD) / Renal Failure

↓ GFR (damaged nephrons)
     ↓
Reduced urea filtration and excretion
     ↓
Urea accumulates in blood → BUN ↑↑↑

Also: ↑ creatinine, ↑ K⁺, metabolic acidosis, anemia
BUN:Creatinine ratio ~10:1 (normal)

2. High Protein Catabolism / Gastrointestinal Bleeding

Excess protein intake OR GI bleed
     ↓
Protein digested to amino acids → increased urea synthesis in liver
     ↓
BUN ↑ (kidneys may be normal → "pre-renal azotemia")

BUN:Creatinine ratio >20:1 suggests pre-renal/GI bleeding cause
Other causes: starvation, fever, burns, post-surgical catabolism, dehydration

BUN:Creatinine Ratio — Quick Reference

Ratio	Interpretation
10–20:1	Normal
>20:1	Pre-renal azotemia OR upper GI bleed
<10:1	Intrinsic renal disease, malnutrition, liver failure

📖 All answers compiled from: Lippincott's Illustrated Reviews Biochemistry (8th ed.), Basic Medical Biochemistry: A Clinical Approach (6th ed.), Harper's Illustrated Biochemistry (32nd ed.), Schwartz's Principles of Surgery (11th ed.), Harrison's Principles of Internal Medicine (22nd ed.)

---Your credits are exhausted. Your daily credits reset tomorrow, or you can purchase a top-up for more.

This is a shared conversation. Sign in to Orris to start your own chat.